XARELTO
XARELTO
Approved
DIN Number
02378604
Drug Class
Human
Market Date
Jan 17, 2012
Company
HC
Bayer Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02378604
AIG Number0152487002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AF01 RIVAROXABAN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:12.04.14
Health Canada Classification
ACTIVE INGREDIENTS (1)
RIVAROXABANActive
Strength: 15 MG
Monograph: RIVAROXABAN